A recent report published by
Infinium Global Research on HIV or AIDS diagnostics market provides in-depth
analysis of segments and sub-segments in the global as well as regional HIV or AIDS
diagnostics market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional HIV or AIDS diagnostics
market over the short term as well as long term. The report is a comprehensive
presentation of trends, forecast and dollar values of global HIV or AIDS
diagnostics market. According to the report, the global HIV or AIDS diagnostics
market is projected to grow at a CAGR of 10.1% over the forecast period of
2019-2025.
HIV or AIDS diagnostic tests are
used to detect the presence of the human immunodeficiency virus which causes
acquired immunodeficiency syndrome. The leading players in the global HIV or
AIDS diagnostics market are focusing on mergers, acquisitions, and collaborations
that expand their market share.
The growing number of individuals
with HIV/AIDS globally drives the growth of the HIV or AIDS diagnostics market.
According to UNAIDS, in 2018, there were around 37.9 million people globally
affected with HIV/AIDS. The surge in the number of blood transfusions and blood
donations causing infections stimulates the growth of the HIV or AIDS
diagnostics market. The rising government initiatives to improve HIV
diagnostics contribute to the growth of the HIV or AIDS diagnostics market. The
increasing awareness about HIV in developing economies promotes the growth of
the HIV or AIDS diagnostics market. In addition, the surge in research and
development for treatment, early diagnosis, and prevention propels the growth
of the HIV or AIDS diagnostics market. On the flip side, high costs of nucleic
acid testing hamper the growth of the HIV or AIDS diagnostics market. Moreover,
technological advancement in HIV or AIDS diagnostics creates numerous opportunities
for the growth of the HIV or AIDS diagnostics market.
Based on geography, the global HIV
or AIDS diagnostics market is classified into North America, Asia-Pacific,
Europe, and the Rest of the World. North America is expected to hold a premium
share in the global HIV or AIDS diagnostics market. The growing prevalence of HIV/AIDS
in North America stimulates the growth of the HIV or AIDS diagnostics market in
North America. Europe is anticipated to grow in the global HIV or AIDS
diagnostics market with a healthy CAGR over the forecast period. The rising
research and development activities and growing awareness about the prevention
of HIV in Europe contribute to the growth of the HIV or AIDS diagnostics market
in Europe. Asia-Pacific region is showing growth in the global HIV or AIDS
diagnostics market owing to the rising number of acute infections.
The report on global HIV or AIDS
diagnostics market covers segments such as product type, test type, and
end-user. On the basis of product type, the sub-markets include kits and
reagents, instruments, and other product types. On the basis of test type, the
sub-markets include rapid tests (POC), ELISA, nucleic acid tests, and other
test types. On the basis of end-user, the sub-markets include hospitals,
private diagnostics laboratories, academic and research institutes, and other
end-users.
The report provides profiles of
the companies in the market such as F. Hoffmann-La Roche Ltd., Abbott Laboratories,
Hologic, Inc., Siemens Healthineers AG, OraSure Technologies, Inc., Chembio
Diagnostic Systems Inc., Danaher Corporation, Becton Dickinson and Company,
Bio-Rad Laboratories, Inc., Alere Inc., and other companies.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of HIV or AIDS diagnostics market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Please Choose One of them.